Exploration and preferential ranking of patient benefits of medical devices: a new and generic instrument for health economic assessments

25 October 2017 - For medical devices, benefits other than direct clinical effects may have a large impact on the patients’ ...

Read more →

Taking patient heterogeneity and preferences into account in health technology assessments

25 October 2017 - The INTEGRATE-HTA project provided methodology to evaluate complex technologies.  ...

Read more →

Call for anti-HIV drug to be funded

26 October 2017 - The AIDS Foundation says it's a fiscal no-brainier to fully fund a drug that prevents the ...

Read more →

Better health care helps fiscal health

24 October 2017 - The Treasurer’s recognition of the importance to the economy of integrated, patient-centred health care injects fresh ...

Read more →

Quentin Bryce in Canberra to support getting breast cancer drug listed on PBS

25 October 2017 - Former governor-general Dame Quentin Bryce has backed efforts to have a life-extending breast cancer drug that ...

Read more →

Hundreds of people with diabetes are set to benefit from the funding of a new treatment that will help prevent blindness

24 October 2017 - From 1 November 2017 dexamethasone implants (brand name Ozurdex) will be funded for eligible people with ...

Read more →

Can ad hoc analyses of clinical trials help personalise treatment decisions?

23 October 2017 - The value of ad hoc analyses of clinical trials may not be clear. Ad hoc analyses are ...

Read more →

AMA submission - Government proposals to increase biosimilar prescribing

19 October 2017 - The Australian Medical Association encourages medical practitioners to offer generic medicine choices when it is safe and ...

Read more →

The serious flaw in Canada's health care system: prescription drugs aren't free

20 October 2017 - It’s often held up as an example to the world, but the Canadian system doesn’t cover essential ...

Read more →

Health care underfunded for too long

23 October 2017 - The death of an elderly man - who broke his hip and died after surgery was ...

Read more →

NICE bars NHS access to Lenvima, Nexavar for thyroid cancer

23 October 2017 - NHS treatment cost regulators have published draft guidelines rejecting funding for Eisai’s Lenvima and Bayer’s Nexavar ...

Read more →

GSK wins U.S. shingles vaccine approval, UK nod for gene therapy

23 October 2017 - GlaxoSmithKline has won U.S. approval for a new and improved shingles vaccine, the second of three ...

Read more →

NICE approves gene therapy for rare ‘bubble baby syndrome’

23 October 2017 - Strimvelis, a treatment for an ultra-rare inherited immune deficiency condition that has been dubbed ‘bubble baby syndrome’ ...

Read more →

NHS to fund gene therapy for 'bubble babies'

23 October 2017 - The NHS will fund gene therapy for the first time, with a £500,000 treatment for “bubble ...

Read more →

Taxpayer-funded drugs 'too expensive for patients’

22 October 2017 - Taxpayer-funded medical research is producing medicines which are increasingly unaffordable for patients who need them, says ...

Read more →